Apoptosis in the central nervous system: Mechanisms and protective strategies

Polish Journal of Pharmacology

Volumn 56, Issue 6, 2004, Pages 689-700

  Kajta, Małgorzata ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

Calpains; Caspases; Estrogens; GSK 3 ; JNKs; Neural development; Neurodegeneration

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AMYLOID BETA PROTEIN; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BENZYLOXYCARBONYLASPARTYLOXYMETHYL FLUOROMETHYL KETONE; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 8; CASPASE 9; CASPASE INHIBITOR; CEP 1347; CYSTEINE PROTEINASE INHIBITOR; CYTOCHROME C; DEATH RECEPTOR; DEATH RECEPTOR 5; DEATH RECEPTOR 6; ESTRADIOL; FAS ANTIGEN; GLYCOGEN SYNTHASE KINASE 3BETA; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INHIBITOR OF APOPTOSIS PROTEIN; NERVE GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN TYROSINE KINASE; RAS PROTEIN; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TACROLIMUS; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALZHEIMER DISEASE; CELL SURVIVAL; DEGENERATIVE DISEASE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HYPOTHESIS; IN VIVO STUDY; MOLECULAR DYNAMICS; NERVE CELL NECROSIS; NERVE DEGENERATION; PATHOPHYSIOLOGY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION;

APOPTOSIS; CENTRAL NERVOUS SYSTEM; NEURONS;

EID: 14244261959     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. Abe-Dohmae S, Harada N, Yamada K, Tanaka R: Bcl-2 gene is highly expressed during neurogenesis in the central nervous system. Biochem Biophys Res Commun, 1993, 191, 915-921.
2. Adachi M, Sohma O, Tsuneishi S, Takada S, Nakamura H: Combination effect of systemic hypothermia and caspase inhibitor administration against hypoxicischemic brain damage in neonatal rats. Pediatric Res, 2001, 50, 590-595.
3. Alzheimer C, Werner S: Fibroblast growth factors and neuroprotection. Adv Exp Med Biol, 2002, 513, 335-351.
4. Bamberger ME, Landreth GE: Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist, 2002, 8, 276-283.
5. Bengzon J, Mohapel P, Ekdahl CT, Lindvall O: Neuronal apoptosis after brief and prolonged seizures. Prog Brain Res, 2002, 135, 111-119.
6. Bhat RV, Leonov S, Luthman J, Scott CW, Lee CM: Interactions between GSK3beta and caspase signalling pathways during NGF deprivation induced cell death. J Alzheimers Dis, 2002, 4, 291-301.
7. Blaschke AJ, Staley K, Chun J: Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development, 1996, 122, 1165-1174.
8. Brusadelli A, Sialino H, Piepoli T, Pollio G, Maggi A: Expression of the estrogen-regulated gene Nip2 during rat brain maturation. Int J Dev Neurosci, 2000, 18, 317-320.
9. Burke RE: Postnatal developmental programmed cell death in dopamine neurons. Ann N Y Acad Sci, 2003, 991, 69-79.
10. Carasantini MT, Rotiroti D, Nappi G, Bagetta G: Neurobiological mediators of neuronal apoptosis in experimental neuroAIDS. Trends Neurosci, 2003, 139, 199-206.
11. Cecconi F, Alvarez-Bolado G, Meyer BI, Roth KA, Gruss P: Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell, 1998, 94, 727-737.
12. Cheema ZF, Wade SB, Sata M, Walsh K, Sohrabji F, Miranda RC: Fas/Apo [Apoptosis]-1 and associated proteins in the differentiating cerebral cortex: induction of caspase dependent cell death and activation of NF-kappaB. J Neurosci, 1999, 19, 1754-1770.
13. Cheema ZF, Santillano DR, Wade SB, Newman JM, Miranda RC: The extracellular matrix, p53 and estrogen compete to regulate cell-surface Fas/Apo-1 suicide receptor expression in proliferating embryonic cerebral cortical precursors, and reciprocally, Fas-ligand modifies estrogen control of cell-cycle proteins. BMC Neurosci, 2004, 5, 11-31.
14. Chen D, Stetler RA, Cao G, Pei W, O'Horo C, Yin XM, Chen J: Characterization of the rat DNA fragmentation factor 35/Inhibitor of caspase-activated DNase (Short form). The endogenous inhibitor of caspase-dependent DNA fragmentation in neuronal apoptosis. J Biol Chem, 2000, 275, 38508-38517.
15. Chong ZZ, Lin SH, Kang JQ, Maiese K: Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase-1, -3, and -8. J Neurosci Res, 2003, 71, 659-669.
16. Clarke P, Tyler KL: Reovirus-induced apoptosis: a minireview. Apoptosis, 2003, 8, 141-150.
17. Cohen P: The role of protein phosphorylation in the hormonal control of enzyme activity. Eur J Biochem, 1985, 151, 439-448.
18. Coronas V, Feron F, Hen R, Sicard G, Jourdan F, Moyse E: In vitro induction of apoptosis or differentiation by dopamine in an immortalised olfactory neuronal cell line. J Neurochem, 1997, 69, 1870-1881.
19. DeBilbao F, Guarin E, Nef P, Vallet P, Giannakopoulos P, Dubois-Dauphin M: Postnatal distribution of cpp32/caspase 3 mRNA in the mouse central nervous system: an in situ hybridisation study. J Comp Neurol, 1999, 409, 339-357.
20. Dohi K, Mizushima H, Nakajo S, Ohtaki H, Matsunaga S, Aruga T, Shioda S: Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways. Regul Pept, 2002, 109, 83-88.
21. Farlie PG, Dringen R, Rees SM, Kannourakis G, Bernard O: Bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl Acad Sci USA, 1995, 92, 4397-4401.
22. Ferrer I: Synaptic pathology and cell death in the cerebellum in Creutzfeldt-Jakob disease. Cerebellum, 2002, 1, 213-222.
23. Fu HJ, Hu QS, Lin ZN, Ren TJ, Song H, Cai CK, Dong SZ: Aluminium-induced apoptosis in cultured cortical neurons and its effect on SAPK/JNK signal transduction pathway. Brain Res, 2003, 980, 11-23.
24. Fukuda K, Kojiro M, Chin J-F: Demonstration of extensive chromatin cleavage in transplanted Morris hepatoma 7777 tissue: apoptosis or necrosis. Am J Pathol, 1993, 142, 935-946.
25. Galfi M, Khali WK, Valkusz Z, Gaspar L, Juhasz A, Julesz J, Molnar J: Functional membrane changes due to tumor induction in rat pituitary cell cultures. J Exp Clin Cancer Res, 2000, 19, 531-535.
26. Garcia-Segura LM, Cardona-Gomez P, Naftolin F, Chowen JA: Estradiol upregulates Bcl-2 expression in adult brain neurons. Neuroreport, 1998, 9, 593-597.
27. Garnier M, Di Lorenzo D, Albertini A, Maggi A: Identification of estrogen-responsive genes in neuroblastoma SK-ER3 cells. J Neurosci, 1997, 17, 4591-4599.
28. Ghoumari AM, Wehrle R, Bernard O, Sotelo C, Dusart I: Implication of Bcl-2 and caspase-3 in age-related Purkinje cell death in murine organotypic culture: an in vitro model to study apoptosis. Eur J Neurosci, 2000, 12, 2935-2949.
29. Gollapudi L, Oblinger MM: Stable transfection of PC12 cells with estrogen receptor (ERalpha): protective effects of estrogen on cell survival after serum deprivation. J Neurosci Res, 1999, 56, 99-108.
30. Gorman AM, Orrenius S, Ceccatelli S: Apoptosis in neuronal cells: role of caspases. Neuroreport, 1998, 9, R49-R55.
31. Groc L, Bezin L, Jiang H, Jackson TS, Levine RA: Bax, Bcl-2, and cyclin expression and apoptosis in rat substantia nigra during development. Neurosci Lett, 2001, 306, 198-202.
32. Herdegen T, Claret FX, Kallunki T, Martin-Villalba A, Winter C, Hunter T, Karin M: Lasting N-terminal phosphorylation of c-Jun and activation of c-Jun N-terminal kinases after neuronal injury. J Neurosci, 1998, 18, 5124-5135.
33. Hetman M, Hsuan S-L, Habas A, Higgins MJ, Xia Z: ERK1/2 antagonizes glycogen synthase kinase-3β-induced apoptosis in cortical neurons. J Biol Chem, 2002, 277, 49577-49584.
34. Honda K, Shimohama S, Sawada H, Kihara T, Nakamizo T, Shibasaki H, Akaike A: Nongenomic antiapoptotic signal transduction by estrogen in cultured cortical neurons. J Neurosci Res, 2001, 64, 466-475.
35. Jellinger KA: Cell death mechanisms in neurodegeneration. J Cell Mol Med, 2001, 5, 1-17.
36. Jenner P: Oxidative stress in Parkinson's disease. Ann Neurol, 2003, 53, Suppl 3, S26-S36.
37. Kajta M, Beyer C: Cellular strategies of estrogen-mediated neuroprotection during brain development. Endocrine, 2003, 1, 3-9.
38. Kajta M, Budziszewska B, Marszal M, Lasoń W: Effects of 17beta-estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. J Physiol Pharmacol, 2001, 52, 437-446.
39. Kajta M, Lasoń W: Oestrogen effects on kainate-induced toxicity in primary cultures of rat cortical neurons. Acta Neurobiol Exp (Wars), 2000, 60, 365-369.
40. Kajta M, Lasoń W, Bień E, Marszał M: Neuroprotective effects of estrone on NMDA-induced toxicity in primary cultures of rat cortical neurons are independent of estrogen receptors. Pol J Pharmacol, 2002, 54, 727-729.
41. Kajta M, Lasoń W, Kupiec T: Effects of estrone on NMDA- and staurosporine-induced changes in caspase-3-like protease activity and LDH-release: time- and tissue-dependent effects in neuronal primary cultures. Neuroscience, 2004, 123, 515-526.
42. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer, 1972, 26, 239-257.
43. Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B, Birnbaum MJ et al.: Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron, 2002, 35, 697-709.
44. Kletner A, Herdegen T: FK506 and its analogs - therapeutic potential for neurological disorders. Curr Drug Target CNS Neurol Disord, 2003, 2, 153-162.
45. Korhonen L, Belluardo N, Lindholm D: Regulation of X-chromosome-linked inhibitor of apoptosis protein in kainic acid-induced neuronal death in the rat hippocampus. Mol Cell Neurosci, 2001, 17, 364-372.
46. Kozlowsky N, Belmaker RH, Agam D: GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol, 2002, 12, 13-25.
47. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA: The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron, 1999, 22, 667-676.
48. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuama H, Rakic P, Flavell RA: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature, 1996, 384, 368-372.
49. Le-Niculescu H, Bonfoco E, Kasuya Y, Claret F-X, Green DR: Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol Cell Biol, 1999, 19, 751-763.
50. Leonard JR, D'Sa C, Cahn BR, Korsmeyer SJ, Roth KA: Bid regulation of neuronal apoptosis. Dev Brain Res, 2001, 128, 187-190.
51. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E et al.: The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development in multiple tissues. Mol Cell, 2000, 6, 1389-1399.
52. Lotto RB, Asavaritikrai P, Vali L, Price DJ: Target-derived neurotrophic factors regulate the death of developing forebrain neurons after a change in their trophic requirements. J Neurosci, 2001, 21, 3904-3910.
53. Lossi L, Merighi A: In vivo cellular and molecular mechanisms of apoptosis in the mammalian CNS. Prog Neurobiol, 2003, 69, 287-312.
54. Mattson MP: Excitotoxic and excitoprotective mechanisms: abundant targets for the prevention and treatment of neurodegenerative disorders. Neuromolecular Med, 2003, 3, 65-94.
55. McKay SE, Oppenheim RW: Lack of evidence for cell deaths among avian spinal cord interneurons during normal development and following removal of targets and afferents. J Neurobiol, 1991, 22, 721-733.
56. McLaughlin BA, Nelson D, Erecinska M, Chesselet M-F: Toxicity of dopamine to striatal neurons in vitro and potential of cell death by a mitochondrial inhibitor. J Neurochem, 1998, 70, 2406-2415.
57. Michaelidis TM, Sendtner M, Cooper JD, Airaksinen MS, Holtman B: Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron, 1996, 17, 75-89.
58. Mizushima H, Zhou CJ, Dohi K, Horai R, Asano M, Iwakura Y, Hirabayashi T et al.: Reduced postischemic apoptosis in the hippocampus of mice deficient in interleukin-1. J Comp Neurol, 2002, 448, 203-216.
59. Monogue AM, Schid AW, Fogarty MP, Campbell VA, Herron CE, Lynch MA: Activation of the c-Jun N-terminal kinase signalling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: a role for interleukin-1 beta. J Biol Chem, 2003, 278, 27971-27980.
60. Mooney SM, Miller MW: Expression of bcl-2, bax, and caspase-3 in the brain of the developing rat. Brain Res Dev Brain Res, 2000, 123, 103-117.
61. Morin C, Zini R, Simon N, Tillemennt JP: Dehydroepiandrosterone and α-estradiol limit the functional alterations of rat brain mitochondria submitted to different experimental stresses. Neuroscience, 2002, 115, 415-424.
62. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davies RJ et al.: Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci, 2001, 21, 7551-7560.
63. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Negishi I, Senju S et al.: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science, 1995, 267, 1506-1510.
64. Nadri C, Kozlowsky N, Agam G: Schizophrenia, neurodevelopment and glycogen synthase kinase-3. Harefuah, 2003, 142, 636-642.
65. Nakagomi S, Suzuki Y, Namikawa K, Kiryu-Seo S, Kiyama H: Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J Neurosci, 2003, 23, 5187-5196.
66. Nat R, Radu E, Regalia T, Popescu LM: Apoptosis in human embryo development: Fas induced apoptosis in brain primary cultures. J Cell Mol Med, 2001, 5, 417-428.
67. Neumar RW, Xu YA, Gada H, Guttmann RP, Siman R: Cross-talk between calpain and caspase proteolytic systems during neuronal apoptosis. J Biol Chem, 2003, 278, 14162-14167.
68. Oppenheim RW: Cell death during development of the nervous system. Ann Rev Neurosci, 1991, 14, 453-501.
69. Oppenheim RW: Programmed cell death. In: Fundamental Neuroscience. Ed. Zigmond MJ, Bloom FE, Landis SC, Roberts JL, Squire LR,. Academic Press, San Diego, London, Boston, New York, Sydney, Tokyo, Toronto, 1999, 581-610.
70. Park C, Sakamaki K, Tachibana O, Tetsumori Y, Junkoh Y, Yonehara S: Expression of Fas antigen in the normal mouse brain. Biochem Biophys Res Commun, 1998, 252, 623-628.
71. Pettmann B, Henderson CE: Neuronal cell death. Neuron, 1998, 20, 633-647.
72. Pike CJ: Estrogen modulates neuronal Bcl-xl expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem, 1999, 72, 1552-1563.
73. Pompeiano M, Blaschke AJ, Flavell RA, Srinivasan A, Chun J: Decreased apoptosis in proliferative and postmitotic regions of the Caspase 3-deficient embryonic central nervous system. J Comp Neurol, 2000, 423, 1-12.
74. Puig B, Ferrer I: Caspase-3-associated apoptotic cell death in excitotoxic necrosis of the enthorinal cortex following intraperitoneal injection of kainic acid in the rat. Neurosci Lett, 2002, 321, 182-186.
75. Putcha GV, Le S, Frank S, Besirli CG, Clark K, Chu B, Alix S et al.: JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron, 2003, 38, 899-914.
76. Rami A, Agarwal R, Botez G, Wincler J: mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res, 2000, 866, 299-312.
77. Raoul C, Henderson CE, Pettmann B: Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol, 1999, 147, 1049-1062.
78. Ray SK, Hogan EL, Banik NL: Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibition. Brain Res Brain Res Rev, 2003, 42, 169-185.
79. Rosenbaum DM, Gupta G, D'Amore J, Singh M, Weidenheim K, Zhang H, Kessler JA: Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemia. J Neurosci Res, 2000, 61, 686-692.
80. Roy N, Mahadevan MS, McLean M, Shutler G, Yaraghi Z, Farahani R, Baird S et al.: The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell, 1995, 80, 167-178.
81. Saporito MS, Thomas BA, Scott RW: MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J Neurochem, 2000, 75, 1200-1208.
82. Sastry PS, Rao KS: Apoptosis in the nervous system. J Neurochem, 2000, 74, 1-20.
83. Sawada H, Ibi M, Kihara T, Urushitani M, Honda K, Nakanishi M, Akaike A et al.: Mechanisms of anti-apoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J, 2000, 14, 1202-1214.
84. Schroeter H, Boyd CS., Ahmed R, Spencer JP, Duncan RF, Rice-Evans C, Cadenas E: c-Jun N-terminal kinase (JNK)-mediated modulation of brain mitochondria function: new target proteins for JNK signalling in mitochondrion-dependent apoptosis. Biochem J, 2003, 372, 359-369.
85. Shimomura A, Nomura R, Senda T: Lithium inhibits apoptosis of mouse neural progenitor cells. Neuroreport, 2003, 14, 1779-1782.
86. Singer CA, Rogers KL, Dorsa DM: Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport, 1998, 9, 2565-2568.
87. Takadera T, Sakamoto Y, Ohyashiki T: NMDA receptor 2B-selective antagonist ifenprodil-induced apoptosis was prevented by glycogen synthase kinase-3 inhibitors in cultured rat cortical neurons. Brain Res, 2004, 1020, 196-203.
88. Tatton WG, Chalmers-Redman R, Brown D, Tatton N: Apoptosis in Parkinson's disease: signals for neuronal degradation. Ann Neurol, 2003, 53, Suppl 3, S61-S72.
89. Voiculescu B, Nat R, Lin E, Iosef C: Apoptosis in human embryo development: 1. Cerebral cortex. J Cell Mol Med, 2000, 4, 284-288.
90. Weaver CE, Park-Chung M, Gibbs TT, Farb DH: 17beta-estradiol protects against NMDA-induced excitotoxicity by direct inhibition of NMDA receptors. Brain Res, 1997, 761, 338-341.
91. Wilson ME, Liu Y, Wise PM: Estradiol enhances Akt activation in cortical explant cultures following neuronal injury. Brain Res Mol Brain Res, 2002, 102, 48-54.
92. Wright LL, Cunningham TJ, Smolen AJ: Developmental neuron death in the rat superior cervical sympathetic ganglion: cell counts and ultrastructure. J Neurocyt, 12, 727-738.
93. Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y, Fong WG et al.: Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci, 1999, 19, 5026-5033.
94. 2+ deficiency. J Neurochem, 2003, 85, 525-533.
95. Yuan J, Yankner BA: Apoptosis in the nervous sytem. Nature, 2000, 407, 802-809.
96. Zhang Y, Tounekti O, Akerman B, Goodyer CG, LeBlanc A: 17-beta-Estradiol induces an inhibitor of active caspases. J Neurosci, 2001, 21, RC176, 1-6.